🇺🇸Core Scientific expects project-level bond financing within 12 months to fund its AMD and neocloud buildout; financing remains pending.

Core Scientific’s Form 10-Q describes project-level bond financing as an expected future funding source, not a completed financing. Management expects to complete it within the next twelve months to support capital expenditures associated with the AMD and neocloud buildout.

The proposed proceeds would fund construction, with cash flows from completed facilities expected to support bond repayment. The supplied disclosure does not specify the proposed issue size, coupon, maturity, collateral package, or closing conditions.

The filing also identifies anticipated liquidity from Tranche 1 warrant exercises and the release of restricted cash by replacing cash collateral with letters of credit. These are prospective sources, and the supplied excerpt does not quantify warrant proceeds or associated incremental dilution.

Construction commitments cover existing customer conversions, greenfield development, and AMD-related capacity delivery, including fit-out costs; substantially all of the cited expenditures are expected within 24 months, and $202.2 million is to be passed through to CoreWeave as invoiced. Separately, the filed earnings presentation says CoreWeave contract receipts flow into a lockbox tied to existing $3.3 billion senior secured notes due 2031—a different financing from the proposed AMD-related project bonds.